2006 AIChE Annual Meeting

Session: Control of polymorphism of APIs or broader value-added materials

Different polymorphs of the same chemical entity display distinct physical properties, such as melting point, solubility, dissolution rate, hygroscopicity, stability, etc. The ability to successfully produce and reproduce specific polymorphic modifications is intricately correlated with the efficiency and speed of materials development, the robustness of manufacturing process, and – ultimately – the stability and quality of the targeted value-added materials. Papers are invited on all aspects of the control of polymorphism and pseudopolymorphism, applicable to pharmaceutical development or manufacture of other value-added materials.

Chair

Peter Karpinski, Novartis Pharmaceuticals Corp.

Co-Chair

Sridhar Desikan, Bristol-Meyers Squibb

Presentations

12:30 PM

12:35 PM

Nancy Cribbin, Andrew Schultz, Kenneth Benjamin, David A. Kofke

12:55 PM

Shekhar K. Viswanath, Ahmad Sheikh, John Tolle, Agnes Pal, James Marek

01:20 PM

01:45 PM

Marco Mazzotti, Lars Vicum, Christian Lindenberg, Jochen Schöll, Jörg Brozio

02:10 PM

Xia Yang, Chi Bun Ching, Wenchuan Wang, Zhenyu Lu

02:35 PM

Paul J. A. Kenis, Guangwen He, Venkateswarlu Bhamidi, Scott R. Wilson, Reginald B.H. Tan, Charles F. Zukoski

02:55 PM